[Interaction of the Embden-Meyerhof pathway and hexose monophosphate shunt in erythrocytes]. 1981

F I Ataullakhanov, and V N Buravtsev, and A M Zhabotinskiĩ, and S B Norina, and A V Pichugin

A mathematical model of glycolysis in human erythrocytes for the interaction between the Embden-Meyerhof and the pentose phosphate pathways has been developed. The characteristic surfaces, i. e. interdependencies between the rates of metabolite flows in both pathways and ATP and NADPH concentrations have been calculated. The model obtained is well correlated with the experimental data on glycolysis characteristic at low rates of the pentose phosphate pathway reactions. The model suggests that NADPH and GSH concentrations should be stabilized. At ATP and NADPH concentrations close to the physiological ones the Embden-Meyerhof and pentose phosphate pathways function practically independently. When the NADPH concentration is decreased below 80% of the physiological value, the system ceases to stabilize the ATP concentration. In its turn, a decrease of ATP concentration results in a corresponding decrease of the maximal rate of the pentose phosphate pathway.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D009249 NADP Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed) Coenzyme II,Nicotinamide-Adenine Dinucleotide Phosphate,Triphosphopyridine Nucleotide,NADPH,Dinucleotide Phosphate, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide Phosphate,Nucleotide, Triphosphopyridine,Phosphate, Nicotinamide-Adenine Dinucleotide
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010428 Pentosephosphates
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006019 Glycolysis A metabolic process that converts GLUCOSE into two molecules of PYRUVIC ACID through a series of enzymatic reactions. Energy generated by this process is conserved in two molecules of ATP. Glycolysis is the universal catabolic pathway for glucose, free glucose, or glucose derived from complex CARBOHYDRATES, such as GLYCOGEN and STARCH. Embden-Meyerhof Pathway,Embden-Meyerhof-Parnas Pathway,Embden Meyerhof Parnas Pathway,Embden Meyerhof Pathway,Embden-Meyerhof Pathways,Pathway, Embden-Meyerhof,Pathway, Embden-Meyerhof-Parnas,Pathways, Embden-Meyerhof
D006600 Hexosephosphates

Related Publications

F I Ataullakhanov, and V N Buravtsev, and A M Zhabotinskiĩ, and S B Norina, and A V Pichugin
January 1965, Acta biologica et medica Germanica,
F I Ataullakhanov, and V N Buravtsev, and A M Zhabotinskiĩ, and S B Norina, and A V Pichugin
May 1987, Acta endocrinologica,
F I Ataullakhanov, and V N Buravtsev, and A M Zhabotinskiĩ, and S B Norina, and A V Pichugin
December 1968, Minerva pediatrica,
F I Ataullakhanov, and V N Buravtsev, and A M Zhabotinskiĩ, and S B Norina, and A V Pichugin
May 1971, Journal of bacteriology,
F I Ataullakhanov, and V N Buravtsev, and A M Zhabotinskiĩ, and S B Norina, and A V Pichugin
July 2003, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
F I Ataullakhanov, and V N Buravtsev, and A M Zhabotinskiĩ, and S B Norina, and A V Pichugin
September 1971, Journal of bacteriology,
F I Ataullakhanov, and V N Buravtsev, and A M Zhabotinskiĩ, and S B Norina, and A V Pichugin
January 1990, Comparative biochemistry and physiology. B, Comparative biochemistry,
F I Ataullakhanov, and V N Buravtsev, and A M Zhabotinskiĩ, and S B Norina, and A V Pichugin
November 1989, European journal of haematology,
F I Ataullakhanov, and V N Buravtsev, and A M Zhabotinskiĩ, and S B Norina, and A V Pichugin
July 2001, American journal of veterinary research,
F I Ataullakhanov, and V N Buravtsev, and A M Zhabotinskiĩ, and S B Norina, and A V Pichugin
October 1976, The Journal of clinical investigation,
Copied contents to your clipboard!